Phillips James Michael

Average Profitability
5.88%
Insider Buys Quantity
8
Insider Buys Sum
$91,556.27
Insider Sells Quantity
7
Insider Sells Sum
$1.09M
2020-03-24SalePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
5,520
0.0036%
$3.05$16,842+182.52%
2020-02-20SalePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
5,050
0.0033%
$4.48$22,624+41.41%
2019-02-19SalePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
14,462
0.0095%
$7.17$103,635-22.42%
2018-09-01PurchasePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
1
<0.0001%
$2.01$2
2018-03-01PurchasePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
5,989
0.0041%
$2.01$12,014+81.78%
2017-09-01PurchasePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
3,244
0.0023%
$4.07$13,208-43.08%
2017-03-01PurchasePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
3,212
0.0027%
$4.07$13,078-30.25%
2016-10-28SalePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
40,000
0.028%
$5.31$212,320-44.6%
2016-09-01PurchasePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
3,147
0.0017%
$4.07$12,813-42.05%
2016-07-29SalePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
40,000
0.0429%
$8.45$337,840-41.4%
2016-04-25SalePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
40,000
0.0267%
$6.12$244,920-24.95%
2016-03-01PurchasePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
3,114
0.0018%
$4.07$12,679-0.94%
2015-09-01PurchasePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
2,289
0.0026%
$4.07$9,320+81.42%
2015-08-07SalePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
33,378
0.0451%
$4.61$154,019+91.19%
2015-03-02PurchasePacific Biosciences of California, Inc.
PACB
SVP, Research & Development
3,754
0.0039%
$4.91$18,443-5.7%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.